|
1. Collection/compilation agency: Australian Bureau of Statistics (ABS).
Collection/compilation type: R&D Survey.
Variables: R&D expenditure.
Scope: Business enterprise sector.
Frequency: Survey in respect of 2001-02.
Periodicity: Onetime.
Classification used: A question asking for percentage of R&D expenditure attributable to biotechnology.
Definition used: OECD definition of biotechnology.
Output: Paper prepared for discussion at the OECD 5th Ad hoc Meeting on Biotechnology Statistics, 2004.
Contact comments: Responses to the biotechnology question were linked to reported fields of science in an attempt to identify fields of science relevant to biotechnology.
Future plans (plans for new collections, strategies, experiences, etc.): A biotechnology firm survey in respect of 2003-04 is currently being developed.
Contact details: http://www.abs.gov.au
Attached are the following surveys:
Annex 1: Survey of Research and Experimental Development Businesses 2001-02
Annex 2: Survey of Research and Experimental Development Businesses 2003-04 (short)
Annex 3: Survey of Research and Experimental Development Businesses 2003-04 (long)
********************
2. Collection/compilation agency: Department of Industry, Tourism and Resources (ITR) in association with AusBiotechnology and consultants - Ernst & Young, Advance Consulting & Evaluation Pty Ltd and Aoris Nova Pty Ltd.
Collection/compilation type: The Directory was produced in association with AusBiotech. The Australian Biotechnology Reports were jointly produced by Ernst & Young and ITR and follow the style of reports produced by Ernst & Young overseas (e.g. for Canada).
The statistics for the Global Partners Report were prepared by Consultants (Advance Consulting & Aoris Nova) who maintain a database of biotechnology firms and activities in accordance with the OECD definition. The database is maintained through publicly available information sources and ad hoc industry surveys which were not prepared in consultation with the Government.
Variables: N/A.
Scope: Any company, public or privately held, which is developing or commercialising biotechnology related products, or who provided expertise and supplies to biotechnology companies as a significant component of their business. Excluded are: not-for-profit enterprises, research institutions and corporate structures which are established for the purposes of administering research grant funds but have no commercial intent.
Frequency: Studies in respect of 1999, 2001 and 2004.
Periodicity: N/A.
Classification used: N/A.
Definition used: The 1999 and 2001 reports defined biotechnology as “the application of all natural sciences and engineering in the direct or indirect use of living organisms, or parts of organisms, in their natural or modified forms, in an innovative manner in the production of goods and services” and noted that “biotechnology was used in the areas of therapeutics, foodstuffs, devices, diagnostics, etc. and/or to improve existing industrial processes. The market application of outputs is typically in the general areas of human health, food production, industrial bio-processing and other public good and environmental settings”.
The 2004 report adopts the OECD definition of biotechnology defining it as “the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living materials for the production of knowledge, goods and services”.
Biotechnology techniques may be applied to different economic sectors. This report groups these sectors as follows:
Output:
Australian Biotechnology Directory.
Ernst &Young, Australian Biotechnology Report 1999, and Australian Biotechnology Report 2001.
Global Partners, Australian Biotechnology 2004, 8 June 2004
Biotech Business Indicators Quarterly.
Contact comments: N/A.
Future plans (plans for new collections, strategies, experiences, etc.): N/A.
Contact details:
http://www.industry.gov.au
http://www.ausbiotech.org
http://www.biotechnology.gov.au
********************
3. Collection/compilation agency: Aoris Nova Pty Ltd and Advance Consulting & Evaluation Pty Ltd.
Collection/compilation type: Annual reviews of biotechnology industry trends.
Variables:
- Number of private and public companies by year, sector, employment.
- Numbers of alliances.
- Numbers of patents to Australian inventors.
- Numbers of new stock exchange listings.
- List of new firms formed.
- Approvals by the regulator.
- Performance of Australian listed companies.
- Lists of grantees and investees in the collection period.
- Also includes information on medical devices in some issues, service providers to the biotechnology industry and investors.
Scope: Australia and New Zealand, discusses trends as well as providing statistics.
Frequency: Annual.
Periodicity: December.
Classification used: N/A.
Definition used: OECD definition of biotechnology.
Output:
2001 Australian Bioindustry Review.
2002 Bio-Industry Review, Australia and New Zealand.
2003 Bio-Industry Review, Australia and New Zealand.
Contact comments: N/A.
Future plans (plans for new collections, strategies, experiences, etc.): Considering global industry comparisons and new issuing schedule.
Contact details: Dr. Kelvin Hopper, Aoris Nova, khopper@aoris.com.au
Dr. Lyndal Thorburn, lyndal@advanceconsulting.com.au
Surveys attached in annex:
2003 Bioindustry Review
Survey of Research and Experimental Development Businesses 2001-2002 - Research Fields, Courses and Disciplines and Socio-Economic Objective Classification
Surveys sent to new firms 2002/03:
- Survey of service providers.
- Survey of Australian biotechnology firms formed in 2002/03.
- Survey of NZ biotechnology firms formed in 2002/03.
|
